Furthermore, MKP-1 expression in the tumor tissues of ovarian cancer patients with stage III/IV disease is significantly lower than in patients with stage I/II [60], and a negative correlation between p-ERK1/2 and MKP-1 expressions has been be established [62]. This evidence concerns the gene DUSP1 and neoplasm.